Select a Sector or Industry
Asset Utilization Rankings for Drug Manufacturers - Other Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Asset Utilization
|
Pro Rating
|
|---|---|---|---|---|
| 1 | DRRX | Durect Corporation | 1.348 | Go Pro |
| 2 | DUSA | DUSA Pharmaceuticals | 1.342 | Go Pro |
| 3 | ISTA | ISTA Pharmaceuticals | 1.210 | Go Pro |
| 4 | NVO | Novo Nordisk | 1.107 | Go Pro |
| 5 | POZN | Pozen | 1.041 | Go Pro |
| 6 | PTX | Pernix Therapeutics | 0.953 | Go Pro |
| 7 | TPI | Tianyin Pharmaceutical | 0.8983 | Go Pro |
| 8 | RDY | Dr. Reddy's Laboratories | 0.883 | Go Pro |
| 9 | GENT | Gentium | 0.8785 | Go Pro |
| 10 | MDCO | The Medicines Company | 0.8199 | Go Pro |
| 11 | SCLN | SciClone Pharmaceuticals | 0.7862 | Go Pro |
| 12 | LCI | Lannett Company | 0.754 | Go Pro |
| 13 | TARO | Taro Pharmaceutical Industries | 0.7258 | Go Pro |
| 14 | NBY | NovaBay Pharmaceuticals | 0.6774 | Go Pro |
| 15 | AGN | Allergan | 0.6689 | Go Pro |
| 16 | SOMX | Somaxon Pharmaceuticals | 0.6443 | Go Pro |
| 17 | FRX | Forest Laboratories | 0.6234 | Go Pro |
| 18 | ALTH | Allos Therapeutics | 0.6208 | Go Pro |
| 19 | SCR | Simcere Pharmaceutical Group | 0.5835 | Go Pro |
| 20 | WCRX | Warner Chilcott | 0.5468 | Go Pro |
| 21 | UTHR | United Therapeutics Corporation | 0.4999 | Go Pro |
| 22 | CBST | Cubist Pharmaceuticals | 0.4694 | Go Pro |
| 23 | PCYC | Pharmacyclics | 0.4639 | Go Pro |
| 24 | DEPO | Depomed | 0.4004 | Go Pro |
| 25 | ENDP | Endo Health Solutions | 0.3938 | Go Pro |
| 26 | SCMP | Sucampo Pharmaceuticals | 0.3857 | Go Pro |
| 27 | MAPP | MAP Pharmaceuticals | 0.2376 | Go Pro |
| 28 | DVAX | Dynavax Technologies Corporation | 0.2278 | Go Pro |
| 29 | APRI | Nexmed | 0.2265 | Go Pro |
| 30 | ISIS | Isis Pharmaceuticals | 0.2023 | Go Pro |
| 31 | PTIE | Pain Therapeutics | 0.1125 | Go Pro |
| 32 | ALXA | Alexza Pharmaceuticals | 0.1081 | Go Pro |
| 33 | RDEA | Ardea Biosciences | 0.0375 | Go Pro |
| 34 | OREX | Orexigen Therapeutics | 0.0322 | Go Pro |
| 35 | CRME | Cardiome Pharma Corporation | 0.0232 | Go Pro |
